CLOXAPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cloxapen, and when can generic versions of Cloxapen launch?
Cloxapen is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in CLOXAPEN is cloxacillin sodium. There are twenty-three drug master file entries for this compound. Additional details are available on the cloxacillin sodium profile page.
Summary for CLOXAPEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Patent Applications: | 3,728 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CLOXAPEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CLOXAPEN
US Patents and Regulatory Information for CLOXAPEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | CLOXAPEN | cloxacillin sodium | CAPSULE;ORAL | 061806-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | CLOXAPEN | cloxacillin sodium | CAPSULE;ORAL | 062233-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | CLOXAPEN | cloxacillin sodium | CAPSULE;ORAL | 062233-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | CLOXAPEN | cloxacillin sodium | CAPSULE;ORAL | 061806-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |